Home LiteratureArticle Details
PMID: 14645521 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo.

Molecular and cellular biology ·Vol. 23 ·No. 24 ·2003-12-00 ·Pages 9094-103

Balsitis SJ, Sage J, Duensing S, Münger K, Jacks T, Lambert PF

Abstract

Although the human papillomavirus (HPV) E7 oncogene is known to contribute to the development of human cervical cancer, the mechanisms of its carcinogenesis are poorly understood. The first identified and most recognized function of E7 is its binding to and inactivation of the retinoblastoma tumor suppressor (pRb), but at least 18 other biological activities have also been reported for E7. Thus, it remains unclear which of these many activities contribute to the oncogenic potential of E7. We used a Cre-lox system to abolish pRb expression in the epidermis of transgenic mice and compared the outcome with the effects of E7 expression in the same tissue at early ages. Mice lacking pRb in epidermis showed epithelial hyperplasia, aberrant DNA synthesis, and improper differentiation. In addition, Rb-deleted epidermis (i.e., epidermis composed of cells with Rb deleted) exhibited centrosomal abnormalities and failed to arrest the cell cycle in response to ionizing radiation. Transgenic mice expressing E7 in skin display the same range of phenotypes. In sum, few differences were detected between Rb-deleted epidermis and E7-expressing epidermis in young mice. However, when both E7 was expressed and Rb was deleted in the same tissue, increased hyperplasia and dysplasia were observed. These findings indicate that inactivation of the Rb pathway can largely account for E7's phenotypes at an early age, but that pRb-independent activities of E7 are detectable in vivo.

MeSH Terms
Animals Base Sequence Cell Cycle/radiation effects Cell Differentiation Cell Division Centrosome/metabolism DNA Primers/genetics Epithelium/metabolism,pathology,virology Female Gene Deletion Genes, Retinoblastoma Genes, Viral Humans Mice Mice, Transgenic Oncogene Proteins, Viral/genetics Oncogenes Papillomaviridae/genetics,pathogenicity Papillomavirus E7 Proteins Phenotype Retinoblastoma Protein/metabolism Skin/metabolism,pathology,virology Uterine Cervical Neoplasms/etiology
Chemicals
DNA Primers Oncogene Proteins, Viral Papillomavirus E7 Proteins Retinoblastoma Protein oncogene protein E7, Human papillomavirus type 16
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Balsitis Scott J
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, 1400 University Avenue, Madison, WI 53706, USA.
Sage Julien
Duensing Stefan
Münger Karl
Jacks Tyler
Lambert Paul F
References (54)
54 references, click to expand
  1. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.
    Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8551-6 PMID: 10411913
  2. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5320-4 PMID: 8202487
  3. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins.
    Genes Dev. 1994 Mar 15;8(6):666-77 PMID: 7926757
  4. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.
    Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10002-7 PMID: 10944189
  5. The role of the centrosome in the development of malignant tumors.
    Curr Top Dev Biol. 2000;49:313-29 PMID: 11005025
  6. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.
    Genes Dev. 2000 Dec 1;14(23):3037-50 PMID: 11114892
  7. The Rb/E2F pathway and cancer.
    Hum Mol Genet. 2001 Apr;10(7):699-703 PMID: 11257102
  8. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype.
    Cancer Res. 2001 Mar 15;61(6):2356-60 PMID: 11289095
  9. "It takes two to tango": understanding how centrosome duplication is regulated throughout the cell cycle.
    Genes Dev. 2001 May 15;15(10):1167-81 PMID: 11358861
  10. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
    J Virol. 2001 Aug;75(15):6737-47 PMID: 11435552
  11. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.
    J Virol. 2001 Aug;75(16):7583-91 PMID: 11462030
  12. Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells.
    Genes Dev. 1994 Sep 15;8(18):2227-40 PMID: 7958891
  13. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.
    Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1654-8 PMID: 7878034
  14. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation.
    J Virol. 1996 Feb;70(2):999-1008 PMID: 8551641
  15. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
    J Virol. 1996 Mar;70(3):1873-81 PMID: 8627712
  16. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
    Cancer Res. 1996 Oct 15;56(20):4620-4 PMID: 8840974
  17. Papillomavirus infections--a major cause of human cancers.
    Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78 PMID: 8876633
  18. Cancer cell cycles.
    Science. 1996 Dec 6;274(5293):1672-7 PMID: 8939849
  19. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.
    Oncogene. 1996 Dec 5;13(11):2323-30 PMID: 8957073
  20. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
    J Virol. 1997 Apr;71(4):2905-12 PMID: 9060648
  21. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts.
    Science. 1999 Feb 5;283(5403):851-4 PMID: 9933170
  22. Cyclin-dependent kinase control of centrosome duplication.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2817-22 PMID: 10077594
  23. Z/AP, a double reporter for cre-mediated recombination.
    Dev Biol. 1999 Apr 15;208(2):281-92 PMID: 10191045
  24. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.
    J Virol. 1997 Aug;71(8):5905-14 PMID: 9223480
  25. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.
    Genes Dev. 1997 Aug 15;11(16):2101-11 PMID: 9284049
  26. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
    Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2290-5 PMID: 9482878
  27. The retinoblastoma gene family: cousins with overlapping interests.
    Trends Genet. 1998 Jun;14(6):223-9 PMID: 9635405
  28. Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation.
    Oncogene. 1998 Aug 27;17(8):949-57 PMID: 9747874
  29. Selection and extended growth of murine epidermal stem cells in culture.
    Exp Cell Res. 1998 Oct 10;244(1):184-95 PMID: 9770361
  30. Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes.
    J Virol. 2001 Aug;75(16):7712-6 PMID: 11462043
  31. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.
    Oncogene. 2001 Nov 26;20(54):7888-98 PMID: 11753671
  32. Disruption of oncogene/tumor suppressor networks during human carcinogenesis.
    Cancer Invest. 2002;20(1):71-81 PMID: 11853005
  33. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.
    J Virol. 2002 Oct;76(20):10559-68 PMID: 12239337
  34. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability.
    Cancer Res. 2003 Jan 15;63(2):476-83 PMID: 12543805
  35. E1A deregulates the centrosome cycle in a Ran GTPase-dependent manner.
    Cancer Res. 2003 Mar 15;63(6):1430-7 PMID: 12649209
  36. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.
    Nature. 2003 Jul 10;424(6945):223-8 PMID: 12853964
  37. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.
    Cancer Res. 2003 Aug 15;63(16):4862-71 PMID: 12941807
  38. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells.
    EMBO J. 1987 Jun;6(6):1741-6 PMID: 3038534
  39. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.
    Cell. 1988 May 20;53(4):539-47 PMID: 2836062
  40. Transformation of rat 3Y1 cells by human papillomavirus type-18 DNA.
    Int J Cancer. 1988 Jun 15;41(6):896-900 PMID: 2836322
  41. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells.
    J Virol. 1989 Mar;63(3):1247-55 PMID: 2536832
  42. Identification of a transforming gene of human papillomavirus type 16.
    J Virol. 1989 Mar;63(3):1465-9 PMID: 2536847
  43. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.
    Oncogene Res. 1988 Sep;3(2):167-75 PMID: 2852339
  44. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
    Science. 1989 Feb 17;243(4893):934-7 PMID: 2537532
  45. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.
    J Virol. 1989 Oct;63(10):4417-21 PMID: 2476573
  46. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
    EMBO J. 1989 Dec 20;8(13):4099-105 PMID: 2556261
  47. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
    EMBO J. 1990 Jan;9(1):153-60 PMID: 2153075
  48. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism.
    J Virol. 1991 Dec;65(12):6922-30 PMID: 1834862
  49. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53 PMID: 1316611
  50. Effects of an Rb mutation in the mouse.
    Nature. 1992 Sep 24;359(6393):295-300 PMID: 1406933
  51. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.
    EMBO J. 1994 Feb 15;13(4):871-8 PMID: 8112300
  52. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    J Virol. 1994 May;68(5):2811-21 PMID: 8151752
  53. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.
    Proc Natl Acad Sci U S A. 1994 May 10;91(10):4382-6 PMID: 8183918
  54. The mitotic machinery as a source of genetic instability in cancer.
    Semin Cancer Biol. 1999 Aug;9(4):289-302 PMID: 10448116
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2003-12-00
Pages
9094-103
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC309665
Subset
IM
Grants
NIGMS NIH HHS · T32 GM007215 · United States
NCI NIH HHS · CA 66980 · United States
NCI NIH HHS · CA 22443 · United States
NIGMS NIH HHS · T32 GM 07215 · United States
NCI NIH HHS · CA 84227 · United States
NCI NIH HHS · P01 CA022443 · United States
NCI NIH HHS · R01 CA066980 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com